ODIN focuses on AI technology for future hospital operations; GATEKEEPER on smart living interventions for health-risk populations.
MEDTRONIC IBERICA SA
Global medtech leader's Spanish arm, coordinating EU projects on AI-driven hospital transformation and smart health monitoring for ageing populations.
Their core work
Medtronic Ibérica is the Spanish subsidiary of Medtronic, one of the world's largest medical device companies. Within H2020, they focus on deploying AI-driven digital health solutions in hospital settings — from smart living environments for ageing populations to AI-powered cancer imaging diagnostics and next-generation hospital operations. They bring deep industry expertise in healthcare delivery systems, acting as a large-scale demonstrator and end-user partner that bridges medical technology with real clinical environments.
What they specialise in
ACTIVAGE deployed IoT smart living environments for ageing well; GATEKEEPER extended this to whole-intervention demonstrators for people at health and social risk.
INCISIVE applies multimodal AI (XAI, deep learning, federated learning) to breast, colorectal, and lung cancer imaging diagnostics.
INCISIVE explores federated learning, blockchain-based data donation, and interoperable health imaging repositories.
How they've shifted over time
Medtronic Ibérica entered H2020 in 2017 focused on IoT-based smart living environments for elderly care (ACTIVAGE), then expanded into broader health risk detection and intervention through smart home demonstrators (GATEKEEPER). From 2020 onward, their work shifted sharply toward AI, deep learning, and data-intensive approaches — cancer imaging AI in INCISIVE and AI-driven hospital-of-the-future concepts in ODIN — signalling a clear pivot from connected living to clinical AI.
Medtronic Ibérica is moving from connected home health monitoring toward AI-powered clinical decision support and hospital-wide digital transformation, making them a strong partner for projects at the intersection of AI and healthcare delivery.
How they like to work
Medtronic Ibérica overwhelmingly leads — they coordinated 3 of their 4 H2020 projects, indicating a preference for driving project direction and large-scale demonstration activities. With 142 unique consortium partners across 20 countries, they operate as a major hub connecting diverse European research and clinical ecosystems. Their coordination of Innovation Actions (IA) with large budgets suggests they excel at managing multi-site deployments and real-world validation, not just research.
Extensive pan-European network spanning 142 unique partners across 20 countries, built primarily through large Innovation Action consortia. This breadth reflects their role as a coordinator connecting hospitals, tech providers, and research institutions across the continent.
What sets them apart
As a subsidiary of the world's largest pure-play medical device company, Medtronic Ibérica brings unmatched scale for real-world clinical deployment and validation that academic or SME partners simply cannot offer. Their progression from IoT ageing solutions to clinical AI positions them uniquely at the intersection of medical devices and digital health intelligence. For consortium builders, they offer both coordination muscle and direct access to hospital networks for piloting and demonstration.
Highlights from their portfolio
- GATEKEEPERLargest single EC contribution (EUR 1.1M), coordinated a major smart living demonstrator for health-risk populations across Europe.
- INCISIVEMarks their pivot into AI-driven cancer diagnostics, combining federated learning, blockchain, and multimodal imaging — their most technically ambitious project.
- ODINTheir most recent coordination, focused on AI-transformed hospital operations — signals their current strategic direction in digital health.